AMZN
Amazon.com, Inc.
AMZN has the edge over GOOS overall, supported by stronger valuation and stronger modeled upside.
GOOS
Canada Goose Holdings Inc.
GOOS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
GOOS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Stable |
GOOS's revenue and profitability are currently healthy, and its balance sheet is stable, but its cash flow is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over GOOS in the historical PE scenario, which offers more potential upside but is not a forecast.
GOOS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $8.28 | — |
| Cheap | 23x | $8.92 | +7.8% |
| Fair | 32x | $12.21 | +48% |
| Expensive | 72x | $27.34 | +230% |
Historical ranges are pointers, not guarantees.
GOOS's PE is 22x, but its earnings don't support one, so it isn't a reliable read right now.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over GOOS on the outlook, with more favorable profitability expectations.
GOOS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for GOOS, with profitability holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over GOOS on earnings, with more consistent year-over-year improvement.
GOOS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.38 | +15% |
| Q1 2026 | $0.14 | -79% |
| Q4 2025 | $0.14 | -73% |
| Q3 2025 | $0.18 | -57% |
| Q2 2025 | $0.33 | -20% |
| Q1 2025 | $0.67 | +60% |
| Q4 2024 | $0.51 | +42% |
| Q3 2024 | $0.42 | +17% |
GOOS's earnings per share have fallen from their peak: $0.38 over the past year, against $1.01 in late 2019.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over GOOS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over GOOS on profitability, with a higher operating margin.
GOOS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $83.6M | +10% |
| Q1 2026 | $319.5M | +18% |
| Q4 2025 | $488.3M | +14% |
| Q3 2025 | $191.6M | +1.8% |
| Q2 2025 | $75.8M | +22% |
| Q1 2025 | $270.4M | +7.4% |
| Q4 2024 | $427.4M | -0.3% |
| Q3 2024 | $188.3M | -4.7% |
GOOS's revenue has grown year over year for six quarters in a row: $84M last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -89% | +59 points |
| Q1 2026 | 14% | 0 points |
| Q4 2025 | 29% | -4.8 points |
| Q3 2025 | -6.5% | -7.1 points |
| Q2 2025 | -147% | -37 points |
| Q1 2025 | 14% | +7.9 points |
| Q4 2024 | 34% | +1 points |
| Q3 2024 | 0.6% | -0.2 points |
GOOS's operating margin was −89% last quarter, up 59 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
GOOS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$137.4M | -$36.1M |
| Q1 2026 | $45.8M | -52% |
| Q4 2025 | $225.3M | -5.2% |
| Q3 2025 | -$87.9M | +$14.1M |
| Q2 2025 | -$101.3M | +$703K |
| Q1 2025 | $94.7M | +147% |
| Q4 2024 | $237.7M | +1.5% |
| Q3 2024 | -$102.1M | -$43.6M |
GOOS has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
GOOS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.9% | -1.9M shares |
| 1 year | -0.9% | -840K shares |
| 3 years | -6.2% | -6.4M shares |
| 5 years | -12% | -13.2M shares |
| Available history | -12% | -13.5M shares |
GOOS has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
GOOS hasn't bought back shares in the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over GOOS on leverage, with a lower net debt burden relative to earnings.
GOOS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.3x | Moderate |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | 2.6x | Moderate |
| Q2 2025 | 2.3x | Moderate |
| Q1 2025 | 1.4x | Healthy |
| Q4 2024 | 3.2x | Elevated |
| Q3 2024 | 2.9x | Moderate |
GOOS's net debt is about 2.3 years of its operating earnings (EBITDA), about the same as a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
GOOS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.0 | Neutral |
| Stochastic | 47.3 | Neutral |
GOOS's weekly RSI is 42 (neutral) and its Stochastic is 47 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over GOOS on valuation relative to its sector.
GOOS PE vs Consumer Cyclical Sector
| Metric | GOOS | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 21% above |
| PE % | 10 | 47 | 37 pts below |
GOOS is trading at 22x earnings, a 21% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over GOOS on trend strength, trading above more of its moving averages.
GOOS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.06 | 2.7% above |
| 20 week MA | $8.47 | 2.2% below |
| 50 week MA | $10.3 | 20% below |
| 100 week MA | $10.8 | 23% below |
| 200 week MA | $12.4 | 33% below |
GOOS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 33% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over GOOS on returns for 2026, with the stronger performance.
GOOS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.6 | $30.9 | -18% |
| 2021 | $30.9 | $37.3 | +21% |
| 2022 | $37.3 | $17.3 | -54% |
| 2023 | $17.3 | $11.9 | -32% |
| 2024 | $11.9 | $9.98 | -16% |
| 2025 | $9.98 | $12.8 | +28% |
| 2026 YTD | $12.8 | $8.28 | -35% |
GOOS has finished lower in four of the last six years. It's down 35% so far in 2026.